Bovine Milk Protein-Derived Preparations and Their Hydrolysates as Sources of ACE-Inhibitory, DPP-IV-Inhibitory, and Antioxidative Peptides Analyzed Using in Silico and in Vitro Protocols
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094323 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anna Iwaniak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Biochemistry, Faculty of Food Science, University of Warmia and Mazury in Olsztyn, Pl. Cieszyński 1, 10-719 Olsztyn-Kortowo, Polan…. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme Inhibitors, Dipeptidyl-Peptidase IV Inhibitors, Antioxidants, Milk Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Minister of Science Republic of Poland, task entitled: The Research Network of Life Sciences Universities for the Development of the Polish Dairy Industry - Re…, APC was funded by the Minister of Science under the Regional Initiative of Excellence Program, Minister of Science Republic of Poland.
Abstract (Originalsprache)
Bovine milk protein preparations (MPPs), namely micellar casein concentrate (MCC), serum protein concentrate (SPC), and MCC with ultrafiltrated buttermilk permeate (MBP), were analyzed as sources of inhibitors of angiotensin-converting enzyme (i.e., ACE) and dipeptidylpeptidase IV (i.e., DPP-IV) as well as antioxidative peptides. The studies involved in silico predictions of the release of biopeptides from bovine milk proteins. Then, all MPPs were subjected to the simulated gastrointestinal digestion using the INFOGEST protocol. Results using a BIOPEP-UWM database tool indicated that 59 biopeptides exhibiting the above-mentioned activities could be produced upon the action of pepsin, trypsin, and chymotrypsin. Thirty-six biopeptides were identified in at least one of the three MPPs subjected to the INFOGEST protocol. MCC before simulated digestion exhibited the strongest ACE-inhibiting activity among all MPPs (IC50 = 1.856 mg/mL). The weakest ACE inhibitory effect was demonstrated for MBP after duodenal digestion (i.e., MBP D; IC50 = 7.627 mg/mL). The above MPP showed the strongest DPP-IV-inhibiting activity (IC50 = 0.0067 mg/mL). All MPPs exhibited antioxidative activity, with the strongest ABTS•+ (i.e., 2,2′-azino-bis(3-ethylbenzotialozline-6-sulfonic acid) radical scavenging effect shown for MBP D (IC50 = 2.754 mg/mL), and the strongest DPPH• (i.e., 2,2-diphenyl-β-picrylhydrazyl) radical scavenging activity (IC50 = 1.238 mg/mL) demonstrated for SPC D. Among all MPPs, SPC D also exhibited the highest FRAP (i.e., Ferric Reducing Antioxidant Power) bioactivity (IC50 = 13.720 mg/mL), whereas MBP D was the MPP with the lowest FRAP potential (IC50 = 20.140 mg/mL). The present study results show the potential of all MPPs as functional additives to support health-beneficial functions of dairy products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Biochemistry, Faculty of Food Science, University of Warmia and Mazury in Olsztyn, Pl. Cieszyński 1, 10-719 Olsztyn-Kortowo, Poland.
- Department of Dairy Science and Quality Management, Faculty of Food Science, University of Warmia and Mazury in Olsztyn, Oczapowskiego 7, 10-719 Olsztyn-Kortowo, Poland.
ORCID-Profile: Anna Iwaniak, Piotr Minkiewicz, Damir Mogut, Justyna Borawska-Dziadkiewicz, Justyna Żulewska, Małgorzata Darewicz
Förderung
- Minister of Science Republic of Poland, task entitled: The Research Network of Life Sciences Universities for the Development of the Polish Dairy Industry - Re…
- APC was funded by the Minister of Science under the Regional Initiative of Excellence Program
- Minister of Science Republic of Poland
- Minister of Science under the Regional Initiative of Excellence Program
Zitieren
APA
Iwaniak, A., Minkiewicz, P., Mogut, D., Borawska-Dziadkiewicz, J., Żulewska, J., & Darewicz, M. (2025). Bovine Milk Protein-Derived Preparations and Their Hydrolysates as Sources of ACE-Inhibitory, DPP-IV-Inhibitory, and Antioxidative Peptides Analyzed Using in Silico and in Vitro Protocols. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094323
Vancouver
Iwaniak A, Minkiewicz P, Mogut D, Borawska-Dziadkiewicz J, Żulewska J, Darewicz M. Bovine Milk Protein-Derived Preparations and Their Hydrolysates as Sources of ACE-Inhibitory, DPP-IV-Inhibitory, and Antioxidative Peptides Analyzed Using in Silico and in Vitro Protocols. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094323
BibTeX
@article{Iwaniak2025,
author = {Iwaniak, Anna and Minkiewicz, Piotr and Mogut, Damir and Borawska-Dziadkiewicz, Justyna and Żulewska, Justyna and Darewicz, Małgorzata},
title = {Bovine Milk Protein-Derived Preparations and Their Hydrolysates as Sources of ACE-Inhibitory, DPP-IV-Inhibitory, and Antioxidative Peptides Analyzed Using in Silico and in Vitro Protocols},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094323}
}
EUVIMED